levodopa has been researched along with Bone Fractures in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chun, S; Chung, SJ; Kim, BJ; Kim, GS; Kim, HK; Kim, MJ; Kim, SR; Koh, JM; Lee, MC; Lee, SH; Ryu, JS | 1 |
| Gnädinger, M; Kaelin-Lang, A; Mellinghoff, HU | 1 |
| Grice, T; Stagg, P | 1 |
| Mosekilde, L; Rejnmark, L; Vestergaard, P | 1 |
| Gao, TJ | 1 |
1 review(s) available for levodopa and Bone Fractures
| Article | Year |
|---|---|
Parkinson's disease and the bones.
Topics: Accidental Falls; Antiparkinson Agents; Bone and Bones; Bone Density; Fractures, Bone; Humans; Levodopa; Osteoporosis; Parkinson Disease; Risk Assessment; Vitamin D | 2011 |
4 other study(ies) available for levodopa and Bone Fractures
| Article | Year |
|---|---|
Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Bone and Bones; Bone Density; Causality; Cohort Studies; Comorbidity; Female; Fractures, Bone; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Male; Middle Aged; Osteoporosis; Prevalence; Risk Factors; Up-Regulation | 2010 |
Nasogastric medication for perioperative Parkinson's rigidity during anaesthesia emergence.
Topics: Amantadine; Anesthesia; Anesthesia Recovery Period; Anesthesia, General; Antiparkinson Agents; Carbidopa; Drug Combinations; Fracture Fixation, Internal; Fractures, Bone; Humans; Humerus; Intraoperative Awareness; Intubation, Gastrointestinal; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Perioperative Care | 2011 |
Fracture risk associated with parkinsonism and anti-Parkinson drugs.
Topics: Adult; Age Factors; Antiparkinson Agents; Carbidopa; Case-Control Studies; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Enzyme Inhibitors; Female; Fractures, Bone; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Parkinsonian Disorders; Risk Factors; Sex Factors; Time Factors | 2007 |
[Promoting effect of L-dopa on experimental fracture healing].
Topics: Animals; Bony Callus; Fractures, Bone; Levodopa; Male; Rats; Rats, Inbred Strains; Wound Healing | 1990 |